[PMID 23829168] The dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in taiwanese breast cancer patients: a 10-year follow-up study
[PMID 24028463] Re-sequencing of the APOAI promoter region and the genetic association of the -75G > A polymorphism with increased cholesterol and low density lipoprotein levels among a sample of the Kuwaiti population
[PMID 18179799] The apolipoprotein AII rs5082 variant is associated with reduced risk of coronary artery disease in an Australian male population.
[PMID 19041386] Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.
[PMID 19057464] Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.
[PMID 21122859] Gene-nutrient interactions and gender may modulate the association between ApoA1 and ApoB gene polymorphisms and metabolic syndrome risk.
[PMID 23021345] Gene-diet interactions on plasma lipid levels in the Inuit population.
[PMID 25176204] Effects of Apolipoprotein A1 Gene rs670 and rs5069 Polymorphisms on the Plasma Lipid Profiles in Healthy Adolescents with Different Body Mass Index
[PMID 25227208] Lower plasma Apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype
[PMID 25653052] Dietary patterns interact with APOA1/APOC3 polymorphisms to alter the risk of the metabolic syndrome: the Tehran Lipid and Glucose Study
[PMID 26824674] Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.